Deaths Prompt Warnings On Rituxan

Law360, New York (December 19, 2006, 12:00 AM EST) -- The U.S. Food and Drug Administration and the drug makers are warning the public that two patients who have taken non-Hodgkins lymphoma and rheumatoid arthritis drug Rituxan have died from a rare nervous system disease.

The FDA said Monday that the patients were taking the drug for systemic lupus erythematosus and developed progressive multifocal leukoencephalopathy or PML, which is a fatal viral infection of the central nervous system. The patients reported the infection as late as a year after their last doses of the drug....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.